Description
Naproxcinod, a nitric oxide-releasing NSAID derivative, significantly improved skeletal muscle strength and fatigue resistance in sedentary and exercise mice, reducing inflammatory infiltration and fibrotic deposition in the myocarduM and diaphragm. In addition to its anti-inflammatory activity, Naproxcinod is a promising candidate for the treatment of Duchenne muscular dystrophy